Cancer Biology & Medicine為季刊，國內外公開發行，由中國科學技術協會主管、中國抗癌協會主辦，主編為我國著名腫瘤學專家郝希山院士。作為中國抗癌協會國內外學術交流的重要媒介，以腫瘤臨床醫師、基礎研究人員、相關交叉學科專業人員及醫學生為讀者對象，向國際學術界展示中國腫瘤防治研究成果，向國內腫瘤學相關專業人員介紹全球腫瘤學前沿進展。刊登稿件范疇：腫瘤表觀遺傳學、腫瘤干細胞生物學、分子與臨床免疫學、腫瘤預防與流行病學、腫瘤標志物、腫瘤影像學、腫瘤臨床試驗、腫瘤靶向治療、腫瘤生物治療、腫瘤個體化醫學與多學科綜合治療。設有述評、綜述、論著、臨床指南、會議報道、病例報告、讀者來信等欄目。

Cancer Biology & Medicine is a peer-reviewed open-access journal published by the Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. Published quarterly, the journal provides innovative and significant information on the biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The scope covers the following topics:● Cancer genetics● Cancer and stem cell biology● Molecular and clinical immunology● Cancer prevention and epidemiology● Cancer biomarkers● Radiation oncology● Oncology clinical trials● Mechanisms of drug sensitivity and resistance● Targeted therapy and immunotherapy● Multidisciplinary treatment and personalized medicine